-+ 0.00%
-+ 0.00%
-+ 0.00%

Bayer venture arm Leaps leads Series A investment in crop biotech Robigo

PUBT·09/17/2026 13:05:48
Listen to the news
Bayer venture arm Leaps leads Series A investment in crop biotech Robigo
  • Bayer’s Leaps unit led a Series A equity financing in crop-protection biotech Robigo.
  • Funding targets U.S. commercialization of engineered microbial biopesticides for soybean Sudden Death Syndrome, targeting a 2028 launch.
  • Capital also backs a second program for fusarium wilt in lettuce and berries, targeting a 2029 launch.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief via Business Wire (Ref. ID: 202609170905BIZWIRE_USPR_____20260917_BW086669) on September 17, 2026, and is solely responsible for the information contained therein.